Claudio Bravo - Concepedia

Author

Claudio Bravo

Rutgers New Jersey Medical School

Also Known As

Bravo, Claudio, C Bravo, C. Bravo, C.A. Bravo, Claudio A Bravo, Claudio A. Bravo, Claudio Andres Bravo, Claudio Bravo

Publications

679

Citations

H-Index

Concepts

All Affiliations

Rutgers New Jersey Medical School Columbia University Irving Medical Center Yokohama City University Albert Einstein College of Medicine Rutgers, The State University of New Jersey

About

Claudio Bravo is an author at Rutgers New Jersey Medical School specializing in medicine, cardiology, and heart failure.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	104
2	Engineering	2	2	158
3	Public Health	2	2	23
4	Health Sciences	1	1	18
5	Biochemistry	1	1	18

Claudio Bravo

Publications

432

Citations

H-Index

Page 1

	Year	Citations
Type 5 Adenylyl Cyclase Increases Oxidative Stress by Transcriptional Regulation of Manganese Superoxide Dismutase via the SIRT1/FoxO3a Pathway Lo Lai, Lin Yan, Shumin Gao, Circulation	2013	100
Photocatalytic EDTA degradation on suspended and immobilized TiO2 Héctor D. Mansilla, Claudio Bravo, R.E. Ferreyra, Journal of Photochemistry and Photobiology A Chemistry Chemical EngineeringEngineeringPhotochemistryInorganic PhotochemistryPhotocatalytic Edta Degradation	2005	98
Multivariate approach to photocatalytic degradation of a cellulose bleaching effluent Montserrat Pérez, Francesc Torrades, José Peral, Applied Catalysis B: Environmental Chemical EngineeringEngineeringPhotochemistryEnvironmental EngineeringDegradation Reaction	2001	60
Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase Kosaku Iwatsubo, Claudio Bravo, Masami Uechi, American Journal of Physiology-Heart and Circulatory Physiology Heart FailureCardiovascular PharmacologyAc5 KnockoutCardiac RegenerationPharmacotherapy	2012	50
Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure Takayuki Yamada, Hiroki Ueyama, Nitin Chopra, Kidney International Reports	2020	27
A Food and Drug Administration–Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion Claudio Bravo, Dorothy E. Vatner, Ronald Pachon, Journal of Pharmacology and Experimental Therapeutics	2016	22
Photocatalytic Degradation of Surfactants With Immobilized TIO<sub>2</sub>: Comparing Two Reaction Systems Cristián Lizama, Claudio Bravo, Cecilia Caneo, Environmental Technology	2005	21
Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study Claudio Bravo, Simin Hua, Amy Deik, Journal of the American Heart Association Heart FailureCardiometabolic RiskMetabolomic ProfilingBrooklyn SitesDiastolic Function	2020	18
A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion Jie Zhang, Daniel Levy, Marko Oydanich, Journal of Molecular and Cellular Cardiology Cardiovascular DiseaseCoronary Artery ReperfusionMedicineCardiovascular PharmacologyMyocardial Infarct Size	2018	13
Explainable Machine Learning Analysis of Right Heart Failure After Left Ventricular Assist Device Implantation Arjun Bahl, Binish Qureshi, Kevin Zhang, ASAIO Journal Heart FailureMachine LearningIntelligent DiagnosticsDevice TherapyExplainable Machine Learning	2022	12

Page 1